Longevity Health Holdings, Inc. (NASDAQ:XAGE – Get Free Report) shares traded down 3.1% on Friday . The stock traded as low as $0.24 and last traded at $0.24. Approximately 134 shares changed hands during mid-day trading, a decline of 95% from the average daily volume of 2,704 shares. The stock had previously closed at $0.2478.
Longevity Health Stock Down 3.1%
The firm has a market cap of $427,680.00, a price-to-earnings ratio of -0.06 and a beta of 0.39. The business’s fifty day moving average is $0.30 and its two-hundred day moving average is $0.31.
About Longevity Health
Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.
Recommended Stories
- Five stocks we like better than Longevity Health
- AST SpaceMobile Stock Sinks as SpaceX Fallout Rattles Space Sector
- Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth
- TSMC Just Gave AI Chip Bulls Another Reason to Stay Confident
- GE Aerospace Faces a Prove-It Moment in Q2 Earnings
Receive News & Ratings for Longevity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Longevity Health and related companies with MarketBeat.com's FREE daily email newsletter.
